Ravinder K. Kaundal

1.6k total citations
54 papers, 1.2k citations indexed

About

Ravinder K. Kaundal is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Ravinder K. Kaundal has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Neurology and 9 papers in Physiology. Recurrent topics in Ravinder K. Kaundal's work include Inflammasome and immune disorders (6 papers), interferon and immune responses (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Ravinder K. Kaundal is often cited by papers focused on Inflammasome and immune disorders (6 papers), interferon and immune responses (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Ravinder K. Kaundal collaborates with scholars based in India, United States and China. Ravinder K. Kaundal's co-authors include Shyam Sunder Sharma, Ashutosh Kumar, Seethalakshmi Iyer, Shyam Sundar Sharma, Manish Arora, Sandeep Vasant More, Pramod Kumar, Arti Dhar, Anil Gulati and Kaushik Shah and has published in prestigious journals such as Cell, Nature Communications and The Journal of Immunology.

In The Last Decade

Ravinder K. Kaundal

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravinder K. Kaundal India 22 449 350 163 142 139 54 1.2k
Tahir Muhammad Pakistan 17 488 1.1× 293 0.8× 277 1.7× 81 0.6× 57 0.4× 58 1.3k
Nelson Humala United States 14 630 1.4× 886 2.5× 262 1.6× 194 1.4× 148 1.1× 22 1.9k
Ludis Morales Colombia 16 476 1.1× 291 0.8× 251 1.5× 175 1.2× 149 1.1× 35 1.2k
Justine Renaud Canada 23 597 1.3× 245 0.7× 163 1.0× 315 2.2× 178 1.3× 32 1.4k
Jizhou Xiang China 23 646 1.4× 196 0.6× 81 0.5× 186 1.3× 79 0.6× 45 1.5k
Jia Cui China 21 681 1.5× 190 0.5× 113 0.7× 163 1.1× 73 0.5× 51 1.3k
Cristina Parrado‐Fernández Sweden 15 454 1.0× 410 1.2× 124 0.8× 92 0.6× 75 0.5× 18 1.0k
Qin Yin China 20 435 1.0× 214 0.6× 151 0.9× 112 0.8× 36 0.3× 56 1.1k
Noha F. Abdelkader Egypt 23 404 0.9× 296 0.8× 173 1.1× 229 1.6× 164 1.2× 45 1.4k
Marwa M. Safar Egypt 25 502 1.1× 277 0.8× 221 1.4× 280 2.0× 230 1.7× 57 1.7k

Countries citing papers authored by Ravinder K. Kaundal

Since Specialization
Citations

This map shows the geographic impact of Ravinder K. Kaundal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravinder K. Kaundal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravinder K. Kaundal more than expected).

Fields of papers citing papers by Ravinder K. Kaundal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravinder K. Kaundal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravinder K. Kaundal. The network helps show where Ravinder K. Kaundal may publish in the future.

Co-authorship network of co-authors of Ravinder K. Kaundal

This figure shows the co-authorship network connecting the top 25 collaborators of Ravinder K. Kaundal. A scholar is included among the top collaborators of Ravinder K. Kaundal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravinder K. Kaundal. Ravinder K. Kaundal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaundal, Ravinder K., et al.. (2025). Amlexanox alleviates renal inflammation and fibrosis by inhibiting cGAS/STING/TBK1 and TGF-β1/Smad signaling. European Journal of Pharmacology. 1007. 178266–178266.
2.
Rahi, Vikrant, et al.. (2025). Urolithin-A Derivative UAS03 Improves Cognitive Deficits and Memory by Activating Nrf2 Pathways to Alleviate Oxidative Stress and Neuroinflammation. ACS Chemical Neuroscience. 16(9). 1815–1826. 1 indexed citations
5.
Kaundal, Ravinder K., et al.. (2025). Neuroprotective effects of Saxagliptin in traumatic brain injury: ameliorating oxidative stress, neuroinflammation, and apoptosis. Metabolic Brain Disease. 40(4). 175–175. 2 indexed citations
6.
Kaundal, Ravinder K., et al.. (2025). Quality by design based hydrogel formulation of 4-Octyl itaconate-loaded nanostructured lipid carriers for epidermal restoration in atopic dermatitis. Journal of Pharmaceutical Investigation. 3 indexed citations
8.
Pandey, Rukmani, et al.. (2024). Neurotoxicity of per- and polyfluoroalkyl substances: Evidence and future directions. The Science of The Total Environment. 955. 176941–176941. 26 indexed citations
9.
Rahi, Vikrant, et al.. (2024). Intranasal administration of berberine-loaded hydrogel ameliorates okadaic acid-induced cognitive deficit in mice. Chemical Engineering Journal. 503. 158197–158197. 2 indexed citations
10.
Kaundal, Ravinder K., et al.. (2023). Role of SIRT3 in mitochondrial biology and its therapeutic implications in neurodegenerative disorders. Drug Discovery Today. 28(6). 103583–103583. 36 indexed citations
11.
Kaundal, Ravinder K., et al.. (2023). Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues. Inflammopharmacology. 32(1). 287–305. 13 indexed citations
12.
Kaundal, Ravinder K., et al.. (2023). The role of cGAS-STING signaling in ischemic stroke: From immune response to therapeutic targeting. Drug Discovery Today. 28(11). 103792–103792. 9 indexed citations
13.
Pandey, Rukmani, et al.. (2023). Role of NLRP3 Inflammasome in Stroke Pathobiology: Current Therapeutic Avenues and Future Perspective. ACS Chemical Neuroscience. 15(1). 31–55. 9 indexed citations
14.
Kaundal, Ravinder K., Anil Kumar Kalvala, & Ashutosh Kumar. (2021). Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction. Molecular Neurobiology. 58(9). 4575–4587. 18 indexed citations
15.
Li, Yongqin, Yuxin Chen, Shaoshuai Mao, et al.. (2020). In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice. Nature Communications. 11(1). 2781–2781. 7 indexed citations
16.
Chaiyachati, Barbara H., Ravinder K. Kaundal, Jiugang Zhao, et al.. (2012). LoxP-FRT Trap (LOFT): a simple and flexible system for conventional and reversible gene targeting. BMC Biology. 10(1). 96–96. 12 indexed citations
17.
Negi, Geeta, Ashutosh Kumar, Ravinder K. Kaundal, Anil Gulati, & Shyam Sunder Sharma. (2009). Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology. 58(3). 585–592. 76 indexed citations
18.
Sharma, Shyam Sunder, Ashutosh Kumar, Manish Arora, & Ravinder K. Kaundal. (2009). Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: Focus on functional, sensorimotor and biochemical changes. Free Radical Research. 43(4). 400–408. 52 indexed citations
19.
Sharma, Rohini, Ravinder K. Kaundal, & Shyam Sunder Sharma. (2008). Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPARγ agonist in LPS-exposed guinea pigs. Pulmonary Pharmacology & Therapeutics. 22(3). 183–189. 21 indexed citations
20.
Sharma, Shyam Sunder, Arti Dhar, & Ravinder K. Kaundal. (2007). FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils. Pharmacological Research. 55(4). 335–342. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026